ARCHIVES

FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

Research Teams Win Honors For Cancer Immunotherapy Work

October 15, 2010

FDA Codifies Rules For Expanded Access, Charging For Drugs In Clinical Trials.

December 22, 2006

Adding Velcade Increased Overall Survival By 13.3 Months at Five-Year Analysis

December 30, 2011

Medenica’s Claims Of Association On CV, Brochures, Challenged By Some Institutions

April 30, 1993

NIH May Claim BRCA1 Rights, While Myriad Files For Patent

October 7, 1994

NCI Advisory Group, Other Cancer Meeting

May 26, 1978